“I am pleased to join a team of individuals committed to growing the life sciences in the BioValley area. It is an honor to be recognized, and at Catalent, we are passionate about innovation and growth. It is exciting to contribute to this culture within the BioValley team,” said Mr. Meissonnier.
Francois BoÃ§quel, President of Alsace BioValley, said, “It is with enthusiasm that we welcome Julien Meissonnier to our Board of Directors. The opportunity for growth in the life sciences within this region is significant. We benefit from first-class academic research, a remarkable capacity for training and a critical mass of leading industries. Directing this organization is a tremendous responsibility and we look forward to Julien's contribution.”
At Catalent, Mr. Meissonnier provides technical and scientific leadership for the development of delivery systems for poorly soluble drugs that lead to approvable regulatory dossiers. His responsibilities include early stage screening activities, developing products, scale-up and technology transfer, directing clinical supplies and supporting product launches. Mr. Meissonnier has 12 years of experience in pharmaceutical development. He received his Engineer Degree in Physico-Chemistry from the ENSI in Caen, France.